|
gptkbp:instanceOf
|
gptkb:brand
gptkb:drug
|
|
gptkbp:approvalYear
|
1991
|
|
gptkbp:ATCCode
|
L03AA02
|
|
gptkbp:biosimilar
|
yes
|
|
gptkbp:contraindication
|
hypersensitivity to filgrastim
|
|
gptkbp:form
|
solution for injection
|
|
gptkbp:genericName
|
gptkb:filgrastim
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Neupogen
|
|
gptkbp:improves
|
production of neutrophils
|
|
gptkbp:indication
|
bone marrow transplantation
neutropenia
chemotherapy-induced neutropenia
peripheral blood progenitor cell collection
severe chronic neutropenia
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Amgen
|
|
gptkbp:marketedIn
|
gptkb:European_Union
gptkb:Japan
gptkb:United_States
|
|
gptkbp:mechanismOfAction
|
granulocyte colony-stimulating factor (G-CSF) analog
|
|
gptkbp:patentExpired
|
yes
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:routeOfAdministration
|
intravenous infusion
subcutaneous injection
|
|
gptkbp:sideEffect
|
splenomegaly
bone pain
allergic reactions
|
|
gptkbp:storage
|
2°C to 8°C
|
|
gptkbp:bfsParent
|
gptkb:Zarxio
gptkb:filgrastim
|
|
gptkbp:bfsLayer
|
8
|